This inventor holds 1 USPTO granted patent. Top assignees: Chulalongkorn University, Kao Corporation. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 13 
1 out of 3,680 
Years Active: 2022
Title: Innovations by Suttisri Rutt: A Pioneer in Endothelin-Converting Enzyme Inhibitors
Introduction
Suttisri Rutt is an innovative inventor based in Bangkok, Thailand. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit endothelin-converting enzymes. His work has implications for both skin whitening and antihypertensive treatments.
Latest Patents
Suttisri Rutt holds a patent for an endothelin-converting enzyme inhibitor. This invention provides a material that effectively inhibits endothelin-converting enzyme activity, which is beneficial for skin whitening and managing hypertension. The active ingredient in this inhibitor includes at least one component selected from a specific group of extracts.
Career Highlights
Throughout his career, Suttisri Rutt has worked with notable organizations such as Kao Corporation and Chulalongkorn University. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Suttisri has collaborated with esteemed colleagues, including Hiroshi Hashimoto and Mitsuyuki Hotta. These partnerships have enriched his research and expanded the impact of his innovations.
Conclusion
Suttisri Rutt's work in developing endothelin-converting enzyme inhibitors showcases his dedication to advancing medical science. His contributions are paving the way for new treatments in dermatology and hypertension management.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile